Dublin, Dec. 05, 2022 (GLOBE NEWSWIRE) -- The "Global Fluorescent in Situ Hybridization Probe Market: Analysis By Product, By Technology, By End User, By Application, By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2027" report has been added to ResearchAndMarkets.com's offering.
The global fluorescent in situ hybridization (FISH) probe market in 2021 was valued at US$1.40 billion. The market value is expected to reach US$2.24 billion by 2027.
A Fluorescent in Situ Hybridization (FISH) Probe refers to a sub-atomic cytogenetic technique that uses fluorescent probes to visualize genetic materials. They are used to identify structural and numerical abnormalities in chromosomes, therapeutic drug monitoring and the identification of rare genetic diseases.
In comparison to the traditionally used standard cytogenetic (cell gene) tests, FISH tests can identify minute genetic changes that are usually missed under the microscope. These probes are therefore widely used for the diagnosis, prediction of outcomes and clinical management of cancer and genetic disorders. The market is expected to grow at a CAGR of 8.21% during the forecast period of 2022-2027.
Market Dynamics:
- Growth Drivers: One of the most important factors impacting the global FISH Probe market is increasing prevalence of cancer and genetic disorders. Furthermore, the growing requirements for in vitro Diagnostics (IVD) testing is driving the FISH Probe market. The development of automated IVD systems for laboratories and hospitals provide efficient, accurate, and error-free diagnoses. Also, IVD products with molecular diagnostic capabilities deliver effective and accurate results. Thus with growth in IVD testing, the Fluorescence In situ hybridization probe market is expected to propel during forecasted years. Furthermore, the market has been growing over the past few years, due to factors such as rapid urbanization, aging population, technological advancements and many other factors.
- Challenges: However, the market has been confronted with some challenges specifically, lack of efficient digitalization solutions and advanced automation capabilities, etc.
- Trends: The market is projected to grow at a fast pace during the forecast period, due to various latest trends such as the escalating demand for big data, FISH automation, etc. The market players are seeking the third generation technologies in the FISH probe field. This includes the addition of powerful big data analytics tools, an AI algorithm for superior speed and accuracy in data interpretation, access to cloud computing for data management, and direct imaging technology for analysis of both dark field (FISH and immunofluorescence) and bright field (H&E, IHC) microscopy. The rising demand of big data is thus expected to influence growth positively in the FISH In situ hybridization probe market during forecasted years.
Impact Analysis of COVID-19 and Way Forward:
In 2020, the global in FISH situ hybridization probe market had seen an acceleration in its growth rate due to the terms left by COVID-19. The concept of in situ hybridization probe plays a crucial role in studying the biology of the novel virus and identifying its potential threats to the human body. Therefore, the governments of various countries and private institutions have increased their funding on in situ hybridization probe to conduct extensive R&D to figure out the related findings. However, the lockdown imposed worldwide has affected the research process by slowing them due to the unavailability of the workforce and created a gap between supply and demand. However, the global in situ hybridization probe market is forecasted to grow at a better growth rate.
Competitive Landscape:
The FISH Probe market is a fragmented market. The industry is also filled with a myriad of small players who are, for the most part, overshadowed by bigger players due to their lack of distinctive product differentiation.
The key players in the global FISH Probe market are:
- Thermo Fisher Scientific Inc.
- Bio-rad Laboratories, Inc.
- Roche Holdings AG
- Bio-Techne Corporation
- Abbott Laboratories
- PerkinElmer, Inc.
- Biocare Medical LLC
- Agilent Technologies
- Sysmex Corporation
- Abnova Corporation
- LGC Group
- Genemed Biotechnologies, Inc.
- Danaher Corporation
Some of the strategies among key players in the market for FISH probe market are mergers, acquisitions, and collaborations. For instance, in 2022, Bio-rad Laboratories, Inc. announced that the company has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WSE NewConnect: SCP), a Warsaw, Poland, based developer of innovative technology solutions for the medical diagnostic and healthcare markets. Whereas, PerkinElmer launched the Cellaca PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to assess multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow.
Key Topics Covered:
1. Executive Summary
2. Introduction
2.1 FISH (Fluorescent In Situ Hybridization) Probe: An Overview
2.1.1 Definition of FISH (Fluorescent In Situ Hybridization) Probe
2.2 FISH Probe Segmentation: An Overview
2.2.1 FISH Probe Segmentation
3. Global Market Analysis
3.1 Global FISH Probe Market: An Analysis
3.1.1 Global FISH Probe Market: An Overview
3.1.2 Global FISH Probe Market by Value
3.1.3 Global FISH Probe Market by Product (Instrument/ Software And Consumables)
3.1.4 Global FISH Probe Market by Technology (Q FISH, Flow FISH And Others)
3.1.5 Global FISH Probe Market by End User (Clinical Procedures, Research And Companion Diagnostics)
3.1.6 Global FISH Probe Market by Application (Cancer Diagnostics And Other)
3.1.7 Global FISH Probe Market by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa)
3.2 Global FISH Probe Market: Product Analysis
3.2.1 Global FISH Probe Market by Product : An Overview
3.2.2 Global Instrument/ Software FISH Probe Market by Value
3.2.3 Global Consumables FISH Probe Market by Value
3.3 Global FISH Probe Market: Technology Analysis
3.3.1 Global FISH Probe Market By Technology: An Overview
3.3.2 Global Q FISH Probe Market By Value
3.3.3 Global Flow FISH Probe Market By Value
3.3.4 Global Other Technology FISH Probe Market By Value
3.4 Global FISH Probe Market: End User Analysis
3.4.1 Global FISH Probe Market By End User: An Overview
3.4.2 Global Clinical Procedures FISH Probe Market By Value
3.4.3 Global Research FISH Probe Market By Value
3.4.4 Global Companion Diagnostics FISH Probe Market By Value
3.5 Global FISH Probe Market: Application Analysis
3.5.1 Global FISH Probe Market By Application: An Overview
3.5.2 Global Cancer Diagnostics FISH Probe Market By Value
3.5.3 Global Other FISH Probe Market By Value
4. Regional Market Analysis
5. Impact of COVID-19
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on FISH Probe Market
5.1.2 Impact of COVID-19 on Research and Development
5.1.3 Post COVID-19 Impact on FISH Probe Market
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Growing Aging Population
6.1.2 Rapid Urbanization
6.1.3 Increasing Prevalence of Cancer and Genetic Disorders
6.1.4 Growing Requirements For In Vitro Diagnostics (IVD) Testing
6.1.5 Technological Advancements
6.1.6 Advantages of FISH Probe
6.2 Challenges
6.2.1 Rising Pathologist Shortages
6.2.2 Lack Of Efficient Digitalization Solutions And Advanced Automation Capabilities
6.3 Market Trends
6.3.1 Escalating Demand for Big Data
6.3.2 FISH Automation
7. Competitive Landscape
7.1 Global FISH Probe Players by Market Share
8. Company Profiles
8.1 Thermo Fisher Scientific Inc.
8.1.1 Business Overview
8.1.2 Operating Segment
8.1.3 Business Strategy
8.2 Bio-rad Laboratories, Inc.
8.2.1 Business Overview
8.2.2 Operating Segment
8.2.3 Business Strategy
8.3 Roche Holdings AG
8.3.1 Business Overview
8.3.2 Business Segment
8.3.3 Business Strategy
8.4 Bio-Techne Corporation
8.4.1 Business Overview
8.4.2 Operating Segment
8.4.3 Business Strategy
8.5 Abbott Laboratories
8.5.1 Business Overview
8.5.2 Operating Segment
8.5.3 Business Strategy
8.6 PerkinElmer, Inc.
8.6.1 Business Overview
8.6.2 Operating Segments
8.6.3 Business Strategy
8.7 Biocare Medical, LLC
8.7.1 Business Overview
8.7.2 Business Strategy
8.8 Agilent Technologies
8.8.1 Business Overview
8.8.2 Business Segment
8.8.3 Business Strategy
8.9 Sysmex Corporation
8.9.1 Business Overview
8.9.2 Business Segment
8.9.3 Business Strategy
8.10 Abnova Corporation
8.10.1 Business Overview
8.11 LGC Group
8.11.1 Business Overview
8.11.2 Business Strategy
8.12 Genemed Biotechnologies, Inc.
8.12.1 Business Overview
8.13 Danaher Corporation
8.13.1 Business Overview
8.13.2 Operating Segments
8.13.3 Business Strategy
For more information about this report visit https://www.researchandmarkets.com/r/hayte9
